These results indicate that SZ-A can effectively counteract obesity-induced activation of the FXR/FGF15 signaling pathway in rats and suppress CYP7A1 expression. This evidence concerns the gene CYP7A1 and obesity due to melanocortin 4 receptor deficiency.